Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michael Verni"'
Autor:
Surena F. Matin, Phillip M. Pierorazio, Nir Kleinmann, John L. Gore, Ahmad Shabsigh, Brian Hu, Karim Chamie, Guilherme Godoy, Scott G. Hubosky, Marcelino Rivera, Michael O’Donnell, Marcus Quek, Jay D. Raman, John J. Knoedler, Douglas Scherr, Christopher Weight, Alon Weizer, Michael Woods, Hristos Kaimakliotis, Angela B. Smith, Jennifer Linehan, Jonathan Coleman, Mitchell R. Humphreys, Raymond Pak, David Lifshitz, Michael Verni, Ifat Klein, Marina Konorty, Dalit Strauss-Ayali, Gil Hakim, Elyse Seltzer, Mark Schoenberg, Seth P. Lerner
Publikováno v:
The Journal of urology. 207(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93716bc2c543c8f5c2d986b81bb22a08
https://pubmed.ncbi.nlm.nih.gov/34982588
https://pubmed.ncbi.nlm.nih.gov/34982588
Autor:
Surena F. Matin, Phillip M. Pierorazio, Nir Kleinmann, John L. Gore, Ahmad Shabsigh, Brian Hu, Karim Chamie, Guilherme Godoy, Scott G. Hubosky, Marcelino Rivera, Michael O’Donnell, Marcus Quek, Jay D. Raman, John J. Knoedler, Douglas Scherr, Christopher Weight, Alon Weizer, Michael Woods, Hristos Kaimakliotis, Angela B. Smith, Jennifer Linehan, Jonathan Coleman, Mitchell R. Humphreys, Raymond Pak, David Lifshitz, Michael Verni, Ifat Klein, Marina Konorty, Dalit Strauss-Ayali, Gil Hakim, Elyse Seltzer, Mark Schoenberg, Seth P. Lerner
Publikováno v:
The Journal of urology. 207(4)
Our goal was to evaluate long-term safety and durability of response to UGN-101, a mitomycin-containing reverse thermal gel, as primary chemoablative treatment for low-grade upper tract urothelial carcinoma.In this open-label, single-arm, multicenter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aec898f5ee055f0b9611b56a81f8fb26
https://pubmed.ncbi.nlm.nih.gov/35191990
https://pubmed.ncbi.nlm.nih.gov/35191990
Autor:
Hristos Z. Kaimakliotis, Brian Hu, Mitchell R. Humphreys, Soamnauth Misir, Jennifer Linehan, Alon Z. Weizer, John C. Gore, Nir Kleinmann, Kim Thacker, Phillip M. Pierorazio, Seth P. Lerner, Marcus L. Quek, Scott G. Hubosky, David A. Lifshitz, Angie Smith, Douglas S. Scherr, Michael Verni, Christopher J. Weight, Surena F. Matin, Elyse Seltzer, Raymond Pak, Jay D. Raman, Mark P. Schoenberg
Publikováno v:
Journal of Urology. 206
INTRODUCTION AND OBJECTIVE:Urothelial cancer is less common, but may be associated with poorer outcomes in women than in men. The literature on gender-based differences in low-grade upper tract uro...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13831f539e1aa593034d35f9d5a3c2a3
https://doi.org/10.1097/ju.0000000000002074.18
https://doi.org/10.1097/ju.0000000000002074.18
Autor:
Kent Chevli, Neal Shore, Andrew Trainer, Angela B. Smith, Daniel Saltzstein, Yaron Ehrlich, Jay D. Raman, Boris Friedman, Richard D'Anna, David Morris, Brian Hu, Mark Tyson, Alexander Sankin, Max Kates, Jennifer Linehan, Douglas Scherr, Steven Kester, Michael Verni, Karim Chamie, Lawrence Karsh, Arnold Cinman, Soumi Lahiri, Andrew Meads, Madlen Malinowski, Nimrod Gabai, Sunil Raju, Elyse Seltzer, Mark Schoenberg, William C. Huang
Publikováno v:
Journal of Urology. 206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22d29fa5358209ba4fe6f15a97ef1c33
https://doi.org/10.1097/ju.0000000000002057.02
https://doi.org/10.1097/ju.0000000000002057.02
Autor:
Marcus L. Quek, Douglas S. Scherr, Karim Chamie, Michael Verni, Christopher J. Weight, Michael A. O’Donnell, Angela R. Smith, John C. Gore, Dalit Strauss-Ayali, Seth P. Lerner, Nir Kleinmann, Surena F. Matin, Hristos Z. Kaimakliotis, Jay D. Raman, Marcelino E. Rivera, Scott G. Hubosky, Elyse Seltzer, Mitchell R. Humphreys, Ahmad Shabsigh, Joshua M. Stern, Michael Woods, Ifat Klein, David A. Lifshitz, Brian Hu, Philip Pierorazio, Gil Hakim, Guilherme Godoy, Mark P. Schoenberg, Jennifer Linehan, Jonathan A. Coleman, Alon Z. Weizer, Marina Konorty
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Low grade (LG) upper tract urothelial cancer (UTUC) accounts for 40% of all UTUC diagnosed in the US. Although LG UTUC has a low risk of progression, radical nephroureter...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ff96d3792c01fcbc3b323128026c41a
https://doi.org/10.1097/ju.0000000000000861.07
https://doi.org/10.1097/ju.0000000000000861.07
Autor:
David L. Morris, Jennifer Linehan, Arnold Cinman, Lawrence Karsch, Jay D. Raman, Boris Friedman, Mark D. Tyson, William J.S. Huang, Michael Verni, K. Kent Chevli, Nimrod Gabai, Angela R. Smith, Robert Kirshoff, Richard D’Anna, Max Kates, Mark P. Schoenberg, Andrew Trainer, Douglas S. Scherr, Brian Hu, Alexander Sankin, Yaron Ehrlich, Neal D. Shore, Elyse Seltzer, Karim Chamie, Daniel Saltzstein, Steven Kester
Publikováno v:
Journal of Urology. 203
Introduction:Low grade, intermediate risk non-muscle invasive bladder cancer (LG IR-NMIBC) is notable for a high rate of disease recurrence yet low risk of disease progression. Patients with LG IR-...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4776f8a463acce0e0c04a0b98a5241bc
https://doi.org/10.1097/ju.0000000000000958.03
https://doi.org/10.1097/ju.0000000000000958.03
Autor:
Mitchell R. Humphreys, Gil Hakim, John L. Gore, Ifat Klein, Michael Woods, Karim Chamie, David A. Lifshitz, Mehrad Adibi, Joshua Stern, Raymond Pak, Michael A. O’Donnell, Scott G. Hubosky, Brian Hu, Guilherme Godoy, Mahul B. Amin, Marcus L. Quek, Phillip M. Pierorazio, Dalit Strauss-Ayali, Angela B. Smith, Surena F. Matin, Jonathan A. Coleman, Seth P. Lerner, Hristos Z. Kaimakliotis, Jay D. Raman, Marcelino E. Rivera, Douglas S. Scherr, Nir Kleinmann, Michael Verni, Christopher J. Weight, John J. Knoedler, Ahmad Shabsigh, Alon Z. Weizer, Jennifer M Linehan, Marina Konorty, Elyse Seltzer, Mark Schoenberg
Publikováno v:
The Lancet. Oncology. 21(6)
Most patients with low-grade upper tract urothelial cancer are treated by radical nephroureterectomy. We aimed to assess the safety and activity of a non-surgical treatment using instillation of UGN-101, a mitomycin-containing reverse thermal gel.In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d6e6b81fd58d3dd919c3450fa06a3fc
https://pubmed.ncbi.nlm.nih.gov/32891427
https://pubmed.ncbi.nlm.nih.gov/32891427
Autor:
Scott G. Hubosky, Mark P. Schoenberg, Douglas S. Scherr, John C. Gore, Marcelino Rivera, Marcus L. Quek, Nir Kleinmann, Angela Smith VChapel, Michael Verni, Christopher J. Weight, Hristos Z. Kaimakliotis, Michael A. O’Donnell, Guy Godoy, Mitchell R. Humphreys, Joshua M. Stern, Alon Z. Weizer, Michael Woods, David A. Lifshitz, Ifat Klein, Ahmad Shabsigh, Philip Pierorazio, Jennifer Linehan, Jonathan A. Coleman, Brian Hu, Karim Chamie, Jay D. Raman, Seth P. Lerner, Surena F. Matin, Elyse Seltzer, Raymond Pak
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Only 30% of UTUC patients receive endoscopic, nephron-sparing treatments due to (1) high grade histology, (2) tumor burden, or (3) unfavorable tumor location. Endoscopic...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ae414ae793e6471c585e4d12b7bef2a
https://doi.org/10.1097/01.ju.0000557508.23335.0a
https://doi.org/10.1097/01.ju.0000557508.23335.0a
Autor:
Michael Verni, Rodney J. Taylor, Stanislav Zelivianski, Carissa Moore, Dmitriy Kondrikov, Ming Fong Lin
Publikováno v:
Biochimica et biophysica acta. 1539(1-2)
The neuroendocrine (NE) cell is a minor cell population in normal human prostate glands. The number of NE cells is increased in advanced hormone-refractory prostate carcinomas (PCA). The mechanism of increased NE cell population in these advanced tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5839303240948bea23aaaacd4ad3b7e8
https://pubmed.ncbi.nlm.nih.gov/11389966
https://pubmed.ncbi.nlm.nih.gov/11389966